Glenmark Pharmaceuticals Inc., USA recalls Ondansetron Orally…
Glenmark Pharmaceuticals Inc., USA recalls Ondansetron Orally Disintegrating Tablets
- Published
- 7 Jan 2026
- Units affected
- 96,948 packs
- Agency
- FDA
- Country
- United States
The hazard
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-157-13
- Brand / company
- Glenmark Pharmaceuticals Inc., USA
- Codes / lots
- Lot #: 19251311, Exp Date April 2027
- Distribution
- Nationwide within the United States
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 7 Jan 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.